July 17, 2017
An FDA advisory panel unanimously recommends the approval of a revolutionary organic cancer treatment.
The treatment called CAR-T THERAPY could provide a second-chance for some children and young adults fighting Leukemia and Lymphoma whose first-line drugs have failed.
It uses genetically engineered cells taken from the patient’s own body, and uses them to naturally attack the cancer.
One medical expert said the development is the most exciting thing he’s seen in his lifetime.